We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.
| Website | http://www.longevc.com |
| Employees | 34 (12 on RocketReach) |
| Founded | 2020 |
| Address | 2001 L St NW, Washington, District of Columbia 20005, US |
| Technologies |
JavaScript
,
HTML
,
Nginx
+4 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Biotech Venture Capital, Biotechnology Investment, Longevity Biotech, Seed Funding Biotech, Longevity Science, Venture Capital Biotech, Biotech Startups, Regenerative Medicine, Biotech Accelerator, Longevity Market, Aging Therapeutics, Cellular Senescence |
| Competitors | Calico Life Sciences, Altos Labs, nirvanaHealth | RxAdvance, Human Longevity, Inc., Elysium Health, MitoQ Limited, UNITY Biotechnology, Rejuvenate Bio, lifespan.com, BioViva USA Inc +23 more (view full list) |
Looking for a particular LongeVC employee's phone or email?
Toms Sturitis is the COO of LongeVC.
12 people are employed at LongeVC.
LongeVC is based in Washington, District of Columbia.